Kenvue Inc. $KVUE Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. reduced its stake in shares of Kenvue Inc. (NYSE:KVUE) by 38.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,388,904 shares of the company’s stock after selling 2,777,353 shares during the period. Assenagon Asset Management S.A. owned approximately 0.23% of Kenvue worth $75,709,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the stock. American Century Companies Inc. increased its position in shares of Kenvue by 22.4% in the 3rd quarter. American Century Companies Inc. now owns 37,046,660 shares of the company’s stock valued at $601,267,000 after acquiring an additional 6,781,640 shares during the period. Independent Franchise Partners LLP lifted its position in Kenvue by 233.4% during the 2nd quarter. Independent Franchise Partners LLP now owns 31,265,574 shares of the company’s stock worth $654,388,000 after acquiring an additional 21,886,537 shares during the period. Norges Bank acquired a new stake in Kenvue during the 2nd quarter worth about $537,418,000. Dimensional Fund Advisors LP grew its stake in Kenvue by 13.5% during the 3rd quarter. Dimensional Fund Advisors LP now owns 23,127,234 shares of the company’s stock valued at $375,377,000 after purchasing an additional 2,747,952 shares during the last quarter. Finally, Van ECK Associates Corp grew its stake in Kenvue by 101.3% during the 3rd quarter. Van ECK Associates Corp now owns 18,361,581 shares of the company’s stock valued at $298,008,000 after purchasing an additional 9,240,434 shares during the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Kenvue Stock Performance

Shares of KVUE stock opened at $17.53 on Wednesday. The stock has a market cap of $33.59 billion, a PE ratio of 22.76, a price-to-earnings-growth ratio of 4.00 and a beta of 0.51. The business has a 50-day simple moving average of $17.99 and a 200-day simple moving average of $17.14. The company has a quick ratio of 0.68, a current ratio of 0.96 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $25.17.

Kenvue (NYSE:KVUE) last posted its earnings results on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.22 by $0.05. The firm had revenue of $3.78 billion for the quarter, compared to analyst estimates of $3.68 billion. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.Kenvue’s revenue for the quarter was up 3.2% compared to the same quarter last year. During the same period last year, the company earned $0.26 earnings per share. On average, equities analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th were given a $0.2075 dividend. This represents a $0.83 annualized dividend and a yield of 4.7%. The ex-dividend date was Wednesday, February 11th. Kenvue’s dividend payout ratio is currently 107.79%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on KVUE shares. Zacks Research upgraded Kenvue from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. Canaccord Genuity Group upped their target price on Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a research report on Wednesday, February 18th. Barclays increased their price target on shares of Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a report on Friday, March 6th. Citigroup raised their price target on shares of Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 18th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Kenvue in a research note on Friday, January 9th. Three analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company. According to data from MarketBeat.com, Kenvue presently has an average rating of “Hold” and an average price target of $19.58.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.